Literature DB >> 23747551

Studying the effects of polycyclic aromatic hydrocarbons on peripheral arterial disease in the United States.

Xiaohui Xu1, Hui Hu, Gregory D Kearney, Haidong Kan, David S Sheps.   

Abstract

PURPOSE: Polycyclic aromatic hydrocarbons are a group of prevalent pollutants which are produced by incomplete combustion of organic materials such as coal, fuel, tobacco smoking and food cooking. The associations between exposures to polycyclic aromatic hydrocarbons (PAHs) and peripheral arterial disease (PAD) have not been well studied.
METHODS: We used the 2001-2004 National Health and Nutrition Examination Survey (NHANES) to investigate the associations between eight monohydroxy urinary metabolites of four PAHs and PAD.
RESULTS: In a logistic regression model, subjects within the middle and highest tertiles of fluorene metabolites, 2-hydroxyfluorene (2-FLUO) and 3-hydroxyfluorene (3-FLUO), and phenanthrene metabolites, 1-hydroxyphenanthrene (1-PHEN) and 2-hydroxyphenanthrene (2-PHEN), had significantly higher prevalence of PAD as compared to subjects within the lowest tertile after adjusting for cigarette smoking, diabetes mellitus and other covariates (For 2-FLUO, the 3rd tertile: OR=2.22, 95% CI=1.13-4.37, p for trend=0.02; For 3-FLUO, the 3rd tertile: OR=2.36, 95% CI: 1.16-4.77, p for trend=0.02; For 1-PHEN, the 3rd tertile: OR=1.84, 95% CI: 1.01-3.37, p for trend=0.04; For 2-PHEN, the 3rd tertile: OR=1.76, 95% CI: 1.07-2.88, p for trend=0.03).
CONCLUSIONS: Our findings suggest that exposure to PAHs may increase the risk of PAD. Further studies are necessary to explore the associations between PAHs and PAD.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  1-NAP; 1-PHEN; 1-PYR; 1-hydroxynaphthalene; 1-hydroxyphenanthrene; 1-hydroxypyrene; 2-FLUO; 2-NAP; 2-PHEN; 2-hydroxyfluorene; 2-hydroxynaphthalene; 2-hydroxyphenanthrene; 3-FLUO; 3-PHEN; 3-hydroxyfluorene; 3-hydroxyphenanthrene; ABI; AORs; Adjusted odds ratios; Ankle–brachial index; CIs; CVD; Cardiovascular disease; Confidence intervals; Environmental exposure; Monohydroxy urinary metabolites of PAHs; NHANES; OH-PAHs; ORs; Odds ratios; PAD; PAHs; Peripheral arterial disease; Peripheral arterial disease (PAD); Polycyclic aromatic hydrocarbons; Polycyclic aromatic hydrocarbons (PAHs); The National Health and Nutrition Examination Survey

Mesh:

Substances:

Year:  2013        PMID: 23747551     DOI: 10.1016/j.scitotenv.2013.04.089

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  17 in total

1.  Serum adipocyte-fatty acid binding protein (FABP4) levels in women from Mexico exposed to polycyclic aromatic hydrocarbons (PAHs).

Authors:  Ángeles C Ochoa-Martínez; Tania Ruíz-Vera; Lucia G Pruneda-Álvarez; Ana K González-Palomo; Claudia I Almendarez-Reyna; Francisco J Pérez-Vázquez; Iván N Pérez-Maldonado
Journal:  Environ Sci Pollut Res Int       Date:  2016-10-31       Impact factor: 4.223

2.  Determination of parent and hydroxy PAHs in personal PM₂.₅ and urine samples collected during Native American fish smoking activities.

Authors:  Oleksii Motorykin; Jill Schrlau; Yuling Jia; Barbara Harper; Stuart Harris; Anna Harding; David Stone; Molly Kile; Daniel Sudakin; Staci L Massey Simonich
Journal:  Sci Total Environ       Date:  2014-10-30       Impact factor: 7.963

3.  Polycyclic aromatic hydrocarbons, brachial artery distensibility and blood pressure among children residing near an oil refinery.

Authors:  Leonardo Trasande; Elaine M Urbina; Mamdouh Khoder; Mansour Alghamdi; Ibrahim Shabaj; Mohammed S Alam; Roy M Harrison; Magdy Shamy
Journal:  Environ Res       Date:  2014-11-20       Impact factor: 6.498

4.  Aryl hydrocarbon receptor activation-mediated vascular toxicity of ambient fine particulate matter: contribution of polycyclic aromatic hydrocarbons and osteopontin as a biomarker.

Authors:  Chia-Chi Ho; Wei-Te Wu; Yi-Jun Lin; Chen-Yi Weng; Ming-Hsien Tsai; Hui-Ti Tsai; Yu-Cheng Chen; Shaw-Fang Yet; Pinpin Lin
Journal:  Part Fibre Toxicol       Date:  2022-06-23       Impact factor: 9.112

5.  Urinary polycyclic aromatic hydrocarbons and measures of oxidative stress, inflammation and renal function in adolescents: NHANES 2003-2008.

Authors:  Shohreh F Farzan; Yu Chen; Howard Trachtman; Leonardo Trasande
Journal:  Environ Res       Date:  2015-11-21       Impact factor: 6.498

6.  Is there any association between urinary metabolites of polycyclic aromatic hydrocarbons and thyroid hormone levels in children and adolescents?

Authors:  Roya Kelishadi; Payam Sobhani; Parinaz Poursafa; Mohammad Mehdi Amin; Karim Ebrahimpour; Silva Hovsepian; Marjan Mansourian; Reza Najafi; Mahin Hashemipour
Journal:  Environ Sci Pollut Res Int       Date:  2017-11-05       Impact factor: 4.223

7.  Metabolism of benzo(a)pyrene by aortic subcellular fractions in the setting of abdominal aortic aneurysms.

Authors:  A Ramesh; P A Prins; P R Perati; P V Rekhadevi; U K Sampson
Journal:  Mol Cell Biochem       Date:  2015-11-03       Impact factor: 3.396

8.  A community study of the effect of polycyclic aromatic hydrocarbon metabolites on heart rate variability based on the Framingham risk score.

Authors:  Yingying Feng; Huizhen Sun; Yuanchao Song; Junzhe Bao; Xiji Huang; Jian Ye; Jing Yuan; Weihong Chen; David C Christiani; Tangchun Wu; Xiaomin Zhang
Journal:  Occup Environ Med       Date:  2014-03-13       Impact factor: 4.402

9.  Evaluating predictive relationships between wristbands and urine for assessment of personal PAH exposure.

Authors:  Holly M Dixon; Lisa M Bramer; Richard P Scott; Lehyla Calero; Darrell Holmes; Elizabeth A Gibson; Haleigh M Cavalier; Diana Rohlman; Rachel L Miller; Antonia M Calafat; Laurel Kincl; Katrina M Waters; Julie B Herbstman; Kim A Anderson
Journal:  Environ Int       Date:  2022-04-04       Impact factor: 13.352

10.  Urinary Biomarkers of Polycyclic Aromatic Hydrocarbons Are Associated with Cardiometabolic Health Risk.

Authors:  Mahsa Ranjbar; Michael A Rotondi; Chris I Ardern; Jennifer L Kuk
Journal:  PLoS One       Date:  2015-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.